Cara Therapeutics | CARA - Attività

Prezzo Delle Azioni
3.66
Cambio Giornaliero
-0.03 -0.81%
Mensile
28.42%
Annuale
-85.92%
Q2 Previsione
3.07




Attività Cambiamento Data
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Assertio Holdings USD 319.77M 46M 2025-09
Cara Therapeutics USD 39.02M 4.73M 2025-09
Cassava Sciences USD 118.35M 11.38M 2025-12
Chugai Pharma JPY 2.27T 203.49B 2026-03
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
J&J USD 200.89B 1.68B 2026-03
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
RedHill Biopharma USD 18.38M 332K 2025-06
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12